Replies to post #31194 on Amarin Corp Plc (AMRN)

[HDGabor]

I could accept info based on facts (source or “wording”). Sometimes it reasonable to blind the source. In this case, two opinion exist:
- and CHD or … equal with CV reduction (by sts66 – unless he agree w my post 31185)
- it’s not equal (mine, but I am not professional)

I am open to accept that Amarin refused an acceptable label, IF somebody write a label, which:
- cover ANCHOR population
- includes the “same” indication as Niaspan and / or Trilipix
- significantly different compare to the proposed indication
Until:
- it did not happened
- the proposed label was unacceptable

ps.:
JL & everybody: I understand your opinion, but please if not "necessary" do not qualify the other posters. (I did it once with BioB re bickering, but I tried to be polite and as I saw it was not a problem for BioB, he did not take it as an insult.)
Kiwi: 60% = 967, 100% = 1.612. One more data - app. average follow-up: 506 days / 17 bmonths / 1,4 years